Approval · Notice of Compliance 2070 · 1999
MICARDIS: Notice of Compliance 2070
Issued August 26, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2070
- Date
- August 26, 1999
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Angiotensin II at1 receptor blocker
Products in this notice
Medicinal ingredients
- TELMISARTAN 40 MG per TAB
- TELMISARTAN 80 MG per TAB